title: Ultrasound as a method to enhance antitumor ability of oncolytic herpes simplex virus for head and neck cancer.
abstract: Low-intensity ultrasound is a useful method to enhance the delivery of drugs to target cells via a range of mechanisms including the transient formation of micropores in the cell membrane, a process known as sonoporation. The effect of ultrasound on oncolytic herpes simplex virus type-1 (HSV-1) infection in oral squamous cell carcinoma (SCC) was examined. Human SCC cell line SAS and oncolytic HSV-1 RH2, which was deficient in the neurovirulent γ134.5 gene and exhibited cell fusion actions, were used. Cells grown in multi-well plates were infected with HSV-1 and exposed to ultrasound in the presence or absence of microbubbles after an adsorption period. The number of plaques was significantly greater than that of the untreated control. SAS cells were inoculated subcutaneously into nude mice and tumors were produced. Tumors were injected with HSV-1 RH2 with or without microbubbles and then exposed to ultrasound through the covering skin. The amount of the virus in tumor tissues 3 days after the injection was higher in tumors treated with HSV-1 RH2 and ultrasound than in tumors treated with RH2 only. The expression of the HSV-1 antigen was also increased by ultrasound and microbubbles. Tumor growth was suppressed with HSV-1 RH2 in combination with ultrasound, especially with microbubbles. These results indicated that ultrasound increased the efficiency of the HSV-1 infection in SAS cells and nude mouse tumors. This method can potentially be useful to enhance the antitumor effects of oncolytic HSV-1 on head and neck cancer treatment.
authors: Department of Oral and Maxillofacial Surgery II, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.
authors: S
authors: S
authors: Okunaga
authors: Department of Oral and Maxillofacial Surgery II, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.
authors: A
authors: A
authors: Takasu
authors: Department of Dental and Oral Surgery, Izumisano Municipal Hospital, Izumisano, Osaka, Japan.
authors: N
authors: N
authors: Meshii
authors: Department of Oral and Maxillofacial Surgery II, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.
authors: T
authors: T
authors: Imai
authors: Department of Oral and Maxillofacial Surgery II, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.
authors: M
authors: M
authors: Hamada
authors: Department of Oral and Maxillofacial Surgery II, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.
authors: S
authors: S
authors: Iwai
authors: Department of Oral and Maxillofacial Surgery II, Osaka University Graduate School of Dentistry, Suita, Osaka, Japan.
authors: Y
authors: Y
authors: Yura
mesh_terms: D000818:Animals; D000956:Antigens, Viral / Q000096:biosynthesis / Q000235:genetics; D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D045744:Cell Line, Tumor; D002522:Chlorocebus aethiops; D005260:Female; D006258:Head and Neck Neoplasms / Q000628:therapy*; D018259:Herpesvirus 1, Human / Q000235:genetics* / Q000378:metabolism; D006801:Humans; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D050130:Oncolytic Virotherapy; D050504:Oncolytic Viruses / Q000235:genetics* / Q000378:metabolism; D014464:Ultrasonic Therapy; D014709:Vero Cells
chemical_list: D000956:Antigens, Viral
references: J Acoust Soc Am. 2000 Jun;107(6):3530-9
references: 10875397
references: Gene Ther. 2008 May;15(9):688-94
references: 18288207
references: Cancer Lett. 2000 Feb 28;149(1-2):189-94
references: 10737723
references: Virol J. 2011 Sep 22;8:446
references: 21939524
references: Gene Ther. 2009 Sep;16(9):1146-53
references: 19571889
references: Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):843-8
references: 9023344
references: J Control Release. 2013 Jul 10;169(1-2):40-7
references: 23562636
references: J Cell Physiol. 2006 Nov;209(2):413-21
references: 16883597
references: Virol J. 2011 Jun 10;8:294
references: 21663640
references: J Virol. 2006 Feb;80(3):1110-20
references: 16414988
references: J Gen Virol. 2013 Apr;94(Pt 4):726-37
references: 23239570
references: Science. 1990 Nov 30;250(4985):1262-6
references: 2173860
references: Gene Ther. 2003 Feb;10(4):292-303
references: 12595888
references: PLoS One. 2009 Aug 04;4(8):e6514
references: 19652721
references: Cancer Res. 2010 May 15;70(10):3890-5
references: 20424118
references: J Clin Oncol. 2009 Dec 1;27(34):5763-71
references: 19884534
references: Hum Gene Ther. 1999 Jul 1;10(10):1599-606
references: 10428205
references: Ultrasound Med Biol. 2011 Nov;37(11):1814-27
references: 21963032
references: J Natl Cancer Inst. 2013 Nov 20;105(22):1701-10
references: 24168971
references: Expert Opin Drug Deliv. 2012 Dec;9(12):1525-38
references: 23121385
references: Phys Med Biol. 2014 Sep 7;59(17):4861-77
references: 25098262
references: Adv Drug Deliv Rev. 2008 Jun 30;60(10):1193-208
references: 18474406
references: Thromb Res. 2008;123(2):274-80
references: 18502476
references: Adv Drug Deliv Rev. 2008 Jun 30;60(10):1153-66
references: 18486268
references: J Oral Pathol Med. 2009 Aug;38(7):572-9
references: 19549112
references: Ultrasound Med Biol. 2006 Jun;32(6):905-14
references: 16785012
references: Clin Cancer Res. 2010 Aug 1;16(15):4005-15
references: 20670951